NetScientific PLC HRS Expands Use of Wanda to All Patients (4607V)
03 November 2017 - 10:00PM
UK Regulatory
TIDMNSCI
RNS Number : 4607V
NetScientific PLC
03 November 2017
NetScientific plc
("NetScientific" or the "Company" or the "Group")
Health Resource Solutions Expands Use of Wanda to All
Patients
London, UK - November 3(rd) 2017 - NetScientific plc
("NetScientific", AIM:NSCI), the transatlantic healthcare IP
commercialisation Group, announces that HRS Home Health (HRS) is
expanding their use of Wanda to all of their home health patients.
This follows a successful trial evaluation involving high-risk,
co-morbid Congestive Heart Failure patients.
Commenting on the news, NetScientific's Chief Executive Officer
and Chairman of Wanda, Francois R. Martelet said: "We are pleased
to announce that HRS will be expanding its use of Wanda to all
patients. We are also delighted to announce that HRS reported a 72%
lower readmission rate for patients using Wanda, in addition to a
high compliancy of 74%. We believe the data demonstrates Wanda's
great technical capabilities, in addition to Wanda's ability to be
integrated into clinician's workflow, both changing lives and
reducing cost."
NetScientific holds a 61% stake on a fully diluted basis in
Wanda.
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite,
CFO
Consilium Strategic
Communications Tel: +44 (0)20 3709 5700
Mary-Jane Elliott Jessica netscientific@consilium-comms.com
Hodgson /
Chris Welsh / Laura
Thornton
Stifel Nicolaus Europe Tel: +44 (0) 20 7710 7600
Limited (NOMAD and Broker)
Jonathan Senior / David
Arch / Ben Maddison
Health Resource Solutions (HRS Home Health) is using Wanda to
increase patient compliance while decreasing readmissions
Summary: Health Resource Solutions is expanding their use of
Wanda to all of their home health patients
After completing a successful program targeting high-risk,
comorbid Congestive Heart Failure patients, Health Resource
Solutions (HRS) is expanding their use of Wanda to HRS home health
patients. HRS is using Wanda's machine learning and clinical
analytics in unison with patient centered goals and HRS's
transition of care guidelines that tie into clinical pathways to
deliver better care for patients. The HRS Model concentrates on
utilizing technology and services to provide the right care at the
right time for the patient. HRS has increased patient compliance
with individual care plans that include patient's goal. The
integration of Wanda's technology with care interventions has
decreased readmissions and costs of care. HRS is expanding this
approach of integrating technology with interventions to its entire
patient population to improve patient outcomes at lower costs.
HRS has found that HF patients that use Wanda have a 72% less
probability of getting readmitted to the hospital. Furthermore,
patients on Wanda showed an average compliancy of 74%, measured by
daily interaction with the Wanda technology and adhering to their
care plan.
Glenn Steigbigel, HRS CEO, noted: "We are very excited by the
results we were able to achieve for our patients by reducing
readmissions to 4.5% and high engagement and compliancy of those
patient. Wanda has enabled us to deliver better care without
increasing the workload for our clinicians, who are more effective
with patients that are more engaged during the recovery process at
home. Wanda is allowing us to identify variances during care
delivery so that we can apply prevention and intervention
techniques. By expanding Wanda, HRS continues to change lives by
improving value for our patients and the clinicians that care for
them. "
"Wanda is all about applying modern software applications
powered by analytics, data science and deep healthcare knowledge in
a meaningful, personal way that is unique to each patient and in
the way nurses, doctors and the full care team can believe and then
act on the information provided." Said Wanda CEO Foad Dabiri.
HRS is the largest privately owned high-tech nursing and
rehabilitation home health agency in Chicago, IL. Since 2005, HRS
has integrated data and technologies with home health services to
measure and increase outcomes and value for patients, caregivers
and clinicians. More information about HRS can be found at
www.healthrs.net
Wanda is dedicated to advancing the effectiveness and efficiency
of medicine by using machine learning and modern software
applications, enabling care providers to intelligently monitor,
communicate with and manage their patients leading to improved
outcomes and efficiencies. More information about Wanda can be
found at www.yourwanda.com.
About NetScientific
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
About Wanda
San Francisco-based Wanda is dedicated to advancing the
effectiveness and efficiency of medicine by using machine learning
in place of conventional technologies and by enabling clinicians to
make more informed care decisions. Wanda recognizes that remote
monitoring and algorithms cannot save lives or reduce
hospitalizations unless the individual and their caregivers are
promptly informed and highly engaged. Through the collaboration of
data science and applied medical research, Wanda has proven that
its inline analytics predict preventable events much better than
conventional methods. Wanda serves as a diligent companion,
providing encouragement and intelligent visual guidance that
simplifies and improves lives, while simultaneously helping
organizations reduce their care delivery costs. Wanda is a
NetScientific portfolio company. More information about Wanda can
be found at www.yourwanda.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRDMMGMGZDGNZZ
(END) Dow Jones Newswires
November 03, 2017 07:00 ET (11:00 GMT)
Netscientific (LSE:NSCI)
Historical Stock Chart
From Apr 2024 to May 2024
Netscientific (LSE:NSCI)
Historical Stock Chart
From May 2023 to May 2024